Barclays Initiates Coverage On Organon with Overweight Rating, Announces Price Target of $28
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Balaji Prasad has initiated coverage on Organon (NYSE:OGN) with an Overweight rating and a price target of $28.
September 21, 2023 | 9:10 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays has initiated coverage on Organon with an Overweight rating and a price target of $28, which could positively impact the stock's performance.
The Overweight rating from Barclays indicates a positive outlook for Organon. The price target of $28 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor interest and a potential rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100